Wegovy and Ozempic both contain the same active ingredient — semaglutide — and are both manufactured by Novo Nordisk. The key difference is their licensed use and dosage. Ozempic is approved for managing type 2 diabetes at doses of 0.5mg and 1mg. Wegovy is specifically licensed for weight management at higher doses, with a standard maintenance dose of 2.4mg and a higher maintenance dose of 7.2mg. Wegovy has been studied in dedicated weight loss clinical trials (the STEP programme) and produces significantly greater weight loss than the doses used in Ozempic. Everslim only prescribes Wegovy for weight management — we do not prescribe Ozempic off-label for weight loss.



